American Century Companies Inc Sage Therapeutics, Inc. Transaction History
American Century Companies Inc
- $157 Billion
- Q1 2025
A detailed history of American Century Companies Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 120,969 shares of SAGE stock, worth $789,927. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,969
Previous 106,792
13.28%
Holding current value
$789,927
Previous $579,000
65.98%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding SAGE
# of Institutions
217Shares Held
49.9MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$34.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$33.2 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29.2 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$17.8 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.6 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $388M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...